TY - JOUR
T1 - Surgery for aortic dilatation in patients with bicuspid aortic valves
T2 - A statement of clarification from the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
AU - Hiratzka, Loren F.
AU - Creager, Mark A.
AU - Isselbacher, Eric M.
AU - Svensson, Lars G.
AU - Nishimura, Rick A.
AU - Bonow, Robert O.
AU - Guyton, Robert A.
AU - Sundt, Thoralf M.
N1 - Publisher Copyright:
© 2016 American College of Cardiology Foundation and American Heart Association, Inc.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Two guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and collaborating societies address the risk of aortic dissection in patients with bicuspid aortic valves and severe aortic enlargement: The "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease" (J Am Coll Cardiol. 2010;55:e27-130) and the "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease" (J Am Coll Cardiol. 2014;63:e57-185). However, the 2 guidelines differ with regard to the recommended threshold of aortic root or ascending aortic dilatation that would justify surgical intervention in patients with bicuspid aortic valves. The ACC and AHA therefore convened a subcommittee representing members of the 2 guideline writing committees to review the evidence, reach consensus, and draft a statement of clarification for both guidelines. This statement of clarification uses the ACC/AHA revised structure for delineating the Class of Recommendation and Level of Evidence to provide recommendations that replace those contained in Section 9.2.2.1 of the thoracic aortic disease guideline and Section 5.1.3 of the valvular heart disease guideline.
AB - Two guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and collaborating societies address the risk of aortic dissection in patients with bicuspid aortic valves and severe aortic enlargement: The "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease" (J Am Coll Cardiol. 2010;55:e27-130) and the "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease" (J Am Coll Cardiol. 2014;63:e57-185). However, the 2 guidelines differ with regard to the recommended threshold of aortic root or ascending aortic dilatation that would justify surgical intervention in patients with bicuspid aortic valves. The ACC and AHA therefore convened a subcommittee representing members of the 2 guideline writing committees to review the evidence, reach consensus, and draft a statement of clarification for both guidelines. This statement of clarification uses the ACC/AHA revised structure for delineating the Class of Recommendation and Level of Evidence to provide recommendations that replace those contained in Section 9.2.2.1 of the thoracic aortic disease guideline and Section 5.1.3 of the valvular heart disease guideline.
KW - AHA Scientific Statements
KW - anticoagulation therapy
KW - heart valves
KW - thoracic aortic aneurysm
KW - thoracic aortic disease
KW - thoracic aortic dissection
KW - valvular heart disease
UR - http://www.scopus.com/inward/record.url?scp=84961226867&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961226867&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2015.12.001
DO - 10.1016/j.jtcvs.2015.12.001
M3 - Article
C2 - 26995623
AN - SCOPUS:84961226867
SN - 0022-5223
VL - 151
SP - 959
EP - 966
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 4
ER -